ELOB
Elongin-B
Also known as: ELOB_HUMAN, SIII, TCEB2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q15370
- Gene
- ELOB
- Ensembl
- ENSG00000103363
- Chromosome
- 16
- Canonical length
- 118 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
This gene encodes the protein elongin B, which is a subunit of the transcription factor B (SIII) complex. The SIII complex is composed of elongins A/A2, B and C. It activates elongation by RNA polymerase II by suppressing transient pausing of the polymerase at many sites within transcription units. Elongin A functions as the transcriptionally active component of the SIII complex, whereas elongins B and C are regulatory subunits. Elongin A2 is specifically expressed in the testis, and capable of forming a stable complex with elongins B and C. The von Hippel-Lindau tumor suppressor protein binds to elongins B and C, and thereby inhibits transcription elongation. Two alternatively spliced transcript variants encoding different isoforms have been described for this gene. Pseudogenes have been identified on chromosomes 11 and 13. [provided by RefSeq, Aug 2008]
Canonical amino-acid sequenceUniProt
118 residues, UniProt reviewed canonical sequence.
>Q15370|ELOB
1 MDVFLMIRRH KTTIFTDAKE SSTVFELKRI VEGILKRPPD EQRLYKDDQL LDDGKTLGEC
61 GFTSQTARPQ APATVGLAFR ADDTFEALCI EPFSSPPELP DVMKPQDSGS SANEQAVQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ELOB can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.38
- Highest tissue expression
- 556 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 556 nTPM
- choroid plexus: 535 nTPM
- amygdala: 473 nTPM
- heart muscle: 436 nTPM
- basal ganglia: 420 nTPM
- hippocampal formation: 405 nTPM
Single-cell type
- late spermatids: 12,046 nCPM
- late primary spermatocytes: 2,194 nCPM
- early spermatids: 2,020 nCPM
- colonocytes: 1,834 nCPM
- esophageal apical cells: 1,509 nCPM
- enterocytes: 1,250 nCPM
Immune cell
- basophil: 3,234 nTPM
- eosinophil: 3,141 nTPM
- total PBMC: 2,386 nTPM
- classical monocyte: 1,689 nTPM
- neutrophil: 1,651 nTPM
- non-classical monocyte: 1,324 nTPM
Brain region
- thalamus: 272 nTPM
- white matter: 268 nTPM
- hippocampal formation: 265 nTPM
- cerebellum: 261 nTPM
- hypothalamus: 261 nTPM
- spinal cord: 260 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.33
- gnomAD pLI
- 0.09
- DepMap mean gene effect
- -1.39
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- positive regulation of proteasomal ubiquitin-dependent protein catabolic process
- protein ubiquitination
- protein-containing complex assembly
- target-directed miRNA degradation
- transcription elongation by RNA polymerase II
- transcription initiation at RNA polymerase II promoter
- ubiquitin-dependent protein catabolic process via the C-end degron rule pathway
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ELOB in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ELOB as an antibody target. Whether an autoantibody or antibody against ELOB could matter depends on whether native ELOB is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ELOB is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ELOB as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...